The 21st century pharmaceutical and biotech sector has come a long way from its roots in 19th century pharmacy. pharmaphorum looks at its evolution over the centuries. The roots of the ...
Clarity Pharmaceuticals Ltd ( ASX:CU6 ) is possibly approaching a major achievement in its business, so we would ...
Getting a plum government gig in Russia is a lot easier if you’ve served in the Kremlin’s presidential bodyguard agency, the Federal Protection Service (bonus points if you’ve saved Vladimir ...
The latest trial over claims that the discontinued heartburn drug Zantac causes cancer ended with a hung jury on Wednesday, as jurors in Chicago were unable to agree on whether Boehringer ...
Although some factories have resumed production after addressing the initial demands, officials and owners report that new ...
Recent investments by major pharmaceutical companies signal a growing confidence in artificial intelligence’s (AI's) ...
Learn about some of the benefits of studying Pharmaceutical and Cosmetic Science at DMU, with Senior Lecturer Paul Bremner, including placement opportunities with global organisations. Our ...
TOKYO -- Takeda Pharmaceutical plans seek approval from U.S. regulators to sell a dengue fever vaccine there, aiming to become the first Japanese company to enter the American vaccine market ...
New Delhi: To maintain dominance in the global pharmaceutical market and bridge the gap between established and emerging players, Union Minister Jitin Prasada has urged the country’s ...
Recursion Pharmaceuticals Inc RXRX shares are trading lower. The company on Tuesday announced Phase 2 data for an investigational treatment for symptomatic Cerebral Cavernous Malformation (CCM).
Well, that was speedy! Hot off the back of yesterday's Indie World and Partner Showcase, Nintendo has revealed two infographics on Twitter, proudly highlighting all the featured titles.
Akums Drugs and Pharmaceuticals IPO Allotment: The initial public offering (IPO) of Akums Drugs and Pharmaceuticals Ltd has closed for subscription and has received strong demand from investors ...